Status:

UNKNOWN

Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children

Lead Sponsor:

Chinese University of Hong Kong

Conditions:

Atopic Dermatitis

Eligibility:

All Genders

4-17 years

Phase:

PHASE2

PHASE3

Brief Summary

The study aims to evaluate the clinical efficacy and safety of the modified Qing-Ying Decoction (mQYD) for the treatment of subacute and chronic atopic dermatitis (AD) in children when compared to the...

Detailed Description

The subjects will come for a screening visit at week 0 (baseline), then at week 6, week 12, and week 16 for Chinese medicine practitioner (CMP) investigators assessments. Eczema Area and Severity Inde...

Eligibility Criteria

Inclusion

  • Age of 4 to 17 (Chinese only);
  • With EASI ≥ 10;
  • Subacute and chronic atopic dermatitis presenting with dry, scaly, erythematous papules and plaques; and
  • Provide written informed consent form (signed by one of their parents)

Exclusion

  • History of allergy to Chinese medicines;
  • AD with Yang deficiency in syndrome differentiation, such as pale looking, always feeling cold, fatigue, chronic diarrhea with loose stool, urinary disorders such as urinary difficulty, excessive urination or incontinence
  • Known overt bacterial infections in the skin;
  • Known pregnancy;
  • Known severe medical conditions, such as cardiovascular, liver or renal dysfunction or Diabetes Mellitus;
  • Having used oral corticosteroids, oral antibiotics, other immunosuppressive or any preparation of oral herbal medicines for the treatment of AD in the past month;
  • Having been diagnosed with scabies, allergic contact dermatitis, seborrheic dermatitis or psoriasis; and
  • Has taken anti-coagulant or anti-platelet drugs in the past month.
  • Has taken any probiotics, prebiotics in the last month
  • Known history of glucose-6-phosphate dehydrogenase (G6PD) deficiency

Key Trial Info

Start Date :

September 10 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2023

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT04419584

Start Date

September 10 2020

End Date

May 1 2023

Last Update

June 22 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Chinese University of Hong Kong

Hong Kong, Hong Kong